全球女性绝育器材市场－市场规模（按细分市场划分）、占有率、监管、报销、干预措施及预测（至2036年）

女性绝育是一种永久性干预措施，透过手术和非手术方法阻断输卵管。随着教育程度和收入的提高，未来大多数国家女性绝育器械的使用率可能会保持稳定（下降和成长速度都非常缓慢）。可逆避孕方法和男性绝育手术正变得越来越受欢迎。输精管结扎术被认为比女性绝育更安全，因为即使手术失败，它也不会增加子宫外孕的风险。然而，新型低成本技术和器械的出现，以及副作用极少或无副作用、可降低性传染病风险的器械的出现，可能会显着抑制输卵管夹和环的市场，并在未来创造新的机会。女性绝育并不能有效预防性传染病，包括爱滋病毒感染。由于这些方法是永久性的，因此建议那些决定未来不再生育的女性采用。

本报告调查并分析了全球女性绝育器材市场，提供了有关区域市场规模、主要趋势、创新产品和技术以及竞争格局的资讯。

市场模型的关键组成部分包括：

已上市的女性绝育设备及不断变化的竞争格局

• 关键产业趋势探讨
• 女性绝育设备市场各细分领域的年度收入和市场预测（2015-2036 年）
• 各细分领域的总干预次数、单位销售、平均售价和市场价值的详细数据

全球、区域与国家层面各市场的探讨

• 按地区划分的定性市场讯息，涵盖全球趋势和各国市场分析
• 女性绝育设备市场的 SWOT 分析
• 女性绝育设备市场竞争动态与趋势探讨

全面了解市场，包括对医疗保健系统的概述，有助于更好地理解市场。此外， "市场准入" 部分还提供有关报销政策和监管环境的信息，以便更深入地了解市场动态。

• 各国医疗保健系统概览
• 报销政策
• 医疗科技监管环境

目标公司

• 犹他医疗产品公司 (Utah Medical Products Inc)
• Gyrus ACMI 公司
• 其他

Female Sterilization Devices Market Size by Segments, Share, Regulatory, Reimbursement, Interventions and Forecast to 2036 is built to visualize quantitative and qualitative market trends within Reproductive Health Devices therapeutic area.

Female Sterilization is a permanent intervention where the fallopian tubes are blocked using surgical and non-surgical techniques. The fallopian tubes are blocked to prevent the sperm from fertilizing the egg, thereby preventing the woman from becoming pregnant.

Female sterilization is a permanent intervention where the fallopian tubes are blocked using surgical and non-surgical techniques. Use of female sterilization devices may remain stable (with very low rates of decline/increase) in future with greater educational attainment and income in most of the countries. Reversible methods and male sterilization are increasing in popularity; vasectomy is considered to be safer than female sterilization as there is no increased risk of ectopic pregnancy if vasectomy fails. However, introduction of new and low cost technologies/devices that reduce the risk of STD's, and cause no/less side effects may hinder the tubal clips/rings market to a large extent and may generate new opportunities in the future. Female sterilization does not protect against sexually transmitted diseases, including HIV. Since, these methods are permanent; these are recommended for women who are sure of their decision of not having any children in the future.

Each of the covered 39 countries color-coded and fully-sourced market models are equipped with epidemiology based indications with intervention volumes. The interactive excel deliverable covers value, volumes, product usage, average selling prices, market size and company share/rank analysis (wherever available). Moreover, analyst comments with qualitative insight offer context for quantitative data.

Key Inclusions of the market model are -

Currently marketed Female Sterilization Devices and evolving competitive landscape -

• Insightful review of the key industry trends.
• Annualized total Female Sterilization Devices market revenue by segment and market outlooks from 2015-2036.
• Granular data on total Interventions, units, average selling prices and market values by segment.

Global, Regional and Country level market specific insights -

• Qualitative market specific information is available with global trends further broken down into regional trends. In addition GlobalData analysts provide unique country specific insights on the market.
• SWOT analysis for Female Sterilization Devices market.
• Competitive dynamics insights and trends provided for Female Sterilization Devices market.

Drive the understanding of the market by getting the veritable big picture including an overview of the healthcare system. In addition the Market Access segment allows you to delve deeper into market dynamics with information on reimbursement policies and the regulatory landscape.

• Country specific overview of the healthcare system.
• Country specific reimbursement policies.
• Country specific medtech regulatory landscape.

Robust methodologies and sources enable the model to provide extensive and accurate overview of the market. Demand and supply-side primary sources are integrated within the syndicated models, including Key Opinion Leaders. In addition, real world data sources are leveraged to determine market trends; these include government procedure databases, hospital purchasing databases, and proprietary online databases.

Companies covered: Utah Medical Products Inc, Gyrus ACMI Inc, and Others.

Countries covered: United States, United Kingdom, Germany, France, Italy, Spain, Brazil, China, India, Russia, Japan, Australia, Canada, Mexico, South Korea, Denmark, Ireland, Netherlands, New Zealand, South Africa, Sweden, Switzerland, Austria, Belgium, Finland, Israel, Norway, Poland, Portugal, Taiwan, Czech Republic, Greece, Hungary, Turkey, Egypt, Saudi Arabia, United Arab Emirates, Argentina, and Chile.

Scope

This Market Model gives important, expert insight you won't find in any other source. The model illustrates qualitative and quantitative trends within the specified market. This model is required reading for -

• CMO executives who must have deep understanding of the Female Sterilization Devices marketplace to make strategic planning and investment decisions.
• Sourcing and procurement executives who must understand crucial components of the supply base in order to make decisions about supplier selection and management.
• Private equity investors that need a deeper understanding of the market to identify and value potential investment targets.

Reasons to Buy

The model will enable you to -

• Develop and design your in-licensing and out-licensing strategies through a review of pipeline products, by identifying key companies.
• Develop business strategies by understanding the trends shaping and driving Female Sterilization Devices market.
• Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the Female Sterilization Devices market in the future.
• Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the company share of market leaders.
• Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Track device sales in the global and country-specific Female Sterilization Devices market from 2015-2036.
• Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.